PODD Common Stock · Transaction Jun 16, 2026 · Filed Jul 6, 2026 · $1,001 to $15,000
Insulet Corp
Veridion Score
BETAHIGH CONF · 6/6 factorsComposite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Why is PODD moving today?
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
PODD overview
Related filings and maps
Congress activity in PODD
PODD Common Stock · Transaction May 27, 2026 · Filed Jun 9, 2026 · $1,001 to $15,000
PODD Common Stock · Transaction May 15, 2026 · Filed Jun 9, 2026 · $1,001 to $15,000
Insulet Corporation - Common Stock · Transaction May 7, 2026 · Filed May 10, 2026 · $100,001 to $250,000
PODD Common Stock · Transaction May 1, 2026 · Filed Jun 9, 2026 · Amount pending receipt enrichment
PODD contract awards, year to date.
Public federal awards linked to this ticker.
PODD lobbying filings, year to date.
Registered lobbying filings matched to Insulet Corp.